Hypopigmentation in the sites of regressed melanoma metastases after successful dacarbazine therapy

photodynamic therapy in disseminated superficial actinic porokeratosis. Clin Exp Dermatol 2002; 27: 703–706. 11 McDonald SG, Peterka ES. Porokeratosis (Mibelli): treatment with topical 5-fluorouracil. J Am Acad Dermatol 1983; 8: 107–110. 12 Shelley WB, Shelley ED. Disseminated superficial porokeratosis: rapid therapeutic response to 5-fluorouracil. Cutis 1983; 32: 139–140. 13 Ahn SJ, Lee HJ, Chang SE, et al. Case of linear porokeratosis: successful treatment with topical 5% imiquimod cream. J Dermatol 2007; 34: 146–147. 14 Hacham-Zadeh S, Holubar K. Etretinate in the treatment of disseminated porokeratosis of Mibelli. Int J Dermatol 1985; 24: 258–260. 15 Dereli T, Ozyurt S, Ozturk G. Porokeratosis of Mibelli: successful treatment with cryosurgery. J Dermatol 2004; 31: 223–227. 16 Barnett JH. Linear porokeratosis: treatment with the carbon dioxide laser. J Am Acad Dermatol 1986; 14: 902–904. 17 Alster TS, Nanni CA. Successful treatment of porokeratosis with 585 nm pulsed dye laser irradiation. Cutis 1999; 63: 265–266. 18 Campbell JP, Voorhees JJ. Etretinate improves localized porokeratosis of Mibelli. Int J Dermatol 1985; 24: 261–263.

[1]  K. Drzewiecki,et al.  Spontaneous regression of metastases from melanoma: review of the literature , 2009, Melanoma research.

[2]  F. Marincola,et al.  Chemotherapy enhances vaccine‐induced antitumor immunity in melanoma patients , 2009, International journal of cancer.

[3]  A. Hauschild,et al.  Short German guidelines: Malignant melanoma , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[4]  N. Georgieva,et al.  Influence of therapy on the antioxidant status in patients with melanoma , 2008, Journal of clinical pharmacy and therapeutics.

[5]  M. Picardo,et al.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. , 2007, Pigment cell research.

[6]  P. Fishman,et al.  Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism , 1994, Cancer Immunology, Immunotherapy.

[7]  D. Spooner,et al.  Spontaneous regression of metastatic malignant melanoma of the parotid gland and neck lymph nodes: a case report and a review of the literature. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[8]  F. Sánchez-Jiménez,et al.  Role of reactive oxygen species in apoptosis: implications for cancer therapy. , 2000, The international journal of biochemistry & cell biology.

[9]  K. Smith,et al.  Nodular melanosis due to epithelial neoplasms: a finding not restricted to regressed melanomas. , 1998, The American Journal of dermatopathology.

[10]  E. Paul,et al.  [Metastasizing malignant melanoma from unknown primary tumor]. , 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[11]  Stewart Fw.  Experiences in spontaneous regression of neoplastic disease in man. , 1952 .

[12]  F. Stewart,et al.  Experiences in spontaneous regression of neoplastic disease in man. , 1952, Texas reports on biology and medicine.